•
Jun 30, 2020

BioLife Q2 2020 Earnings Report

BioLife Solutions' second quarter results were announced, showing revenue growth driven by acquisitions and increased adoption of its bioproduction tools.

Key Takeaways

BioLife Solutions reported a 48% increase in total revenue for Q2 2020, reaching $9.9 million, driven by acquisitions completed in the second half of 2019. Biopreservation media accounted for 67% of the total revenue. The company gained 88 new customers in the first half of 2020 and raised $106 million year-to-date to support its consolidation strategy.

Total revenue increased by 48% to $9.9 million compared to Q2 2019.

Biopreservation media revenue was $6.7 million, representing 67% of total revenue.

The company gained 48 new customers during the quarter.

Raised gross proceeds of $86 million through an oversubscribed public offering of common stock subsequent to the quarter close.

Total Revenue
$9.92M
Previous year: $6.7M
+48.0%
EPS
-$0.01
Previous year: $0.04
-125.0%
Gross margin
48.7%
Adjusted gross margin
56.6%
Previous year: 72.2%
-21.6%
Operating loss
$510K
Gross Profit
$4.82M
Previous year: $4.74M
+1.7%
Cash and Equivalents
$29.9M
Previous year: $19.6M
+52.4%
Free Cash Flow
$4.1M
Previous year: -$178K
-2402.2%
Total Assets
$114M
Previous year: $51.3M
+122.2%

BioLife

BioLife

BioLife Revenue by Segment

Forward Guidance

Due to uncertainty regarding the impact of COVID-19, the Company withdrew its financial guidance for 2020 on May 1, 2020.

Revenue & Expenses

Visualization of income flow from segment revenue to net income